1st Heidelberg International Symposium on Diabetic Complications
27. - 28.10.2014
The conference will highlight recent exciting developments in key areas of diabetes and its complications, particularly focusing on the role of reactive metabolites, diabetes signaling pathways as well as clinical aspects and treatment options for diabetic patients. We envision contributions allowing the audience to gain an overview of the recent progress on these fundamental topics in biomedicine.
Speakers
Prof. Brüning Jens | Universität Köln Institut für Genetik | Köln (Germany) |
Prof. Brownlee Michael | Albert Einstein College of Medicine Jack and Pearl Resnick Campus | New York (USA) |
Prof. Carmeliet Peter | KU Leuven VIB Vesalius Research Center | Leuven (Belgium) |
Prof. Cooper Mark | Baker IDI Heart and Diabetes Institute NHMRC Australia Fellow | Melbourne (Australia) |
Prof. Friedlander Martin | The Scripps Research Institute Department of Cell Biology | La Jolla (USA) |
Prof. Hardie D. Grahame | University of Dundee College of Life Sciences Division Cell Signalling and Immunology | Dundee (UK) |
Prof. Häring Hans-Ulrich | Universitätsklinikum Tübingen Medizinischen Klinik IV | Tübingen (Germany) |
Prof. Isermann Berend | Otto-von-Guericke-Universität Magdeburg Institut für Klinische Chemie und Pathobiochemie | Magdeburg (Germany) |
Prof. Roden Michael | Deutschen Diabetes-Zentrum DDZ Arbeitsgruppe Energiestoffwechsel | Düsseldorf (Germany) |
Prof. Stumvoll Michael | Universitätsklinikum Leipzig Klinik für Endokrinologie/Nephrologie und Diabeteszentrum DDG | Leipzig (Germany) |
Prof. Tschöp Matthias | Helmholz Zentrum München Institute for Diabetes and Obesity (IDO) | München (Germany) |
Prof. Chavakis Triantafyllos | University Clinic Carl-Gustav-Carus Dresden University of Technology Division on Vascular Inflammation, Diabetes and Kidney, Department of Medicine | Dresden (Germany) |
Program
Monday, October 27
08.00- 08.50 | Registration and Coffee |
08.50 | Stephan Herzig, Welcome |
09.00 – 12.30 | Session I: Systemic Mechanisms and Clinical Diabetes |
09.00 | Enrique Saez |
09.30 | Casper Schalkwijk |
10.00 | Berend Isermann |
10.30 | Coffee break |
11.00 | Hermann Haller |
11.30 | Peter Carmeliet |
12.00 | Martin Friedlander |
12.30 -14.30 | Lunch break and poster session posters are displayed in Foyer |
14.30 – 17.00 | Session II: Vascular Signaling and Diabetes |
14.30 | Jens Brüning |
15.00 | Per-Henrik Groop |
15.30 | Michael Brownlee |
16.00 | Mark Cooper |
16.30 | Coffee break |
17.00 | Triantafyllos Chavakis |
17.30 | Matthias Tschöp |
Tuesday, October 28
09.00 – 12.00 | Session III: Intracellular Signaling and Metabolites in Diabetes |
09.00 | Michael Stumvoll |
09.30 | Michael Roden |
10.00 | Hans-Ulrich Häring |
10.30 | coffee break |
11.00 | Morris Birnbaum |
11.30 | D. Grahame Hardie |
12.00 | Hans-Peter Hammes, Concluding Remarks |
12.10-13.30 | lunch break |
Organizers
Uniklinikum Heidelberg
Prof. Nawroth
DKFZ
Prof. Herzig
Uniklinikum Mannheim
Prof. Hammes
CRC 1118 Late Diabetic complications